Effect of theophylline on endogenous hydrogen sulfide in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 671s Year: 2006
Endogenous hydrogen sulfide (H2 S) in serum and sputum as novel biomarker of asthma Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012
Vasorelaxant effect of hydrogen sulfide (H2 S) in human isolated pulmonary vessels Source: Eur Respir J 2005; 26: Suppl. 49, 579s Year: 2005
A new method for measuring hydrogen peroxide concentration in exhaled air in stable COPD patients: reproducibilityand stability Source: Eur Respir J 2001; 18: Suppl. 33, 460s Year: 2001
Elevated concentration of exhaled hydrogen peroxide in patients with asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 166s Year: 2001
Relationship between hydrogen peroxide levels in exhaled breath condensate and long term changes in small airway function of patients with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 585s Year: 2007
Increased concentration of hydrogen peroxide (H2 O2 ) in expired breath condensate of patients with lung cancer and stable chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001
The anti-proliferative effect of endogenous and exogenous hydrogen sulfide upon human airway smooth muscle Source: Annual Congress 2010 - Airway smooth muscle cells Year: 2010
Concentrations of the hydrogen peroxide and nitrite in exhaled breath condensate as markers of inflammatory lung diseases Source: Annual Congress 2008 - COPD Year: 2008
Exercise increases the hydrogen peroxide release in exhaled breath condensate Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012
Hydrogen sulphide donors prevent hyperreactivity of mice tracheas in an in vitro lipopolysaccharide-induced inflammation model Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018
Endogenous hydrogen sulfide reduces airway hyperresponsiveness and airway inflammation in a rat model of chronic obstructive pulmonary disease Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009
Acute neutrophilic airway inflammation is associated with a decrease in pulmonary ascorbic acid concentration but not an elevation of exhaled hydrogen peroxide Source: Eur Respir J 2004; 24: Suppl. 48, 596s Year: 2004
The dynamic of pH, hydrogen peroxide and nitrite in exhaled breath condensate from patients with COPD and asthma exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
Enhanced level of hydrogen peroxide in expired breath correlates with the plasma concentration of TNFa in patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 556s Year: 2004
Evaluation of hydrogen perioxide in breath condensate in children with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 143s Year: 2002
Impact of theophylline/corticosteroid combination therapy on sputum hydrogen sulfide levels in patients with COPD Source: Eur Respir J 2014; 43: 1504-1506 Year: 2014
Variation of exhaled hydrogen peroxide in stable COPD patients and matched healthy persons over time Source: Eur Respir J 2001; 18: Suppl. 33, 148s Year: 2001
Non-enzymatic hydrogen peroxide scavenging properties of normal human airway secretions Source: Eur Respir J 2003; 22: Suppl. 45, 456s Year: 2003
DUOX1-mediated hydrogen peroxide release regulates sodium transport in bronchiolar epithelial cells Source: Annual Congress 2011 - Epithelial cell biology Year: 2011